HAMEL ASSOCIATES, INC.

Position in AZN — Astrazeneca PLC

CIK 1599760 Center Valley, PA

Position in AZN

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$844,946

-$64,435 QoQ

Shares Held

4,456

-3.4% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.32%

of 13F equity value

Holder Rank

#708

of 1,459 holders

Holding Since

Mar 2026

2 quarters on record

Healthcare · as of Jun 30, 2026

HAMEL ASSOCIATES, INC. holds $48,231,824 across 6 Drug Manufacturers - General names. AZN ranks #6 (1.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	64,967	$16,499,668
2	MRK	Merck & Co., Inc.	92,513	$11,887,920
3	AMGN	Amgen Inc	20,068	$7,267,024
4	NVS	Novartis AG	40,423	$6,335,092
5	ABBV	AbbVie Inc.	21,448	$5,397,174
6	AZN	Astrazeneca PLC This page	4,456	$844,946

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$844,946	4,456	-3.4%	Shares	Sole	2026-07-27
2026-03-31	$909,381	4,611	—	Shares	Sole	2026-05-07
No filing history on record for this holder in this stock.